Home Categories API Orlistat
A6562412

Orlistat , >97.0%(HPLC) , 96829-58-2

Synonym(s):
(−)-Tetrahydrolipstatin;N-Formyl-L-leucine (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester;Orlistat;Ro-18-0647

CAS NO.:96829-58-2

Empirical Formula: C29H53NO5

Molecular Weight: 495.73

MDL number: MFCD05662360

EINECS: 639-755-1

Pack Size Price Stock Quantity
100MG RMB31.20 In Stock
250MG RMB39.20 In Stock
1G RMB56.80 In Stock
5G RMB100.00 In Stock
25G RMB476.00 In Stock
100G RMB1268.00 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Melting point: <50 °C
Boiling point: 615.9±30.0 °C(Predicted)
alpha  D20 -32.0° (c = 1 in chloroform)
Density  0.976±0.06 g/cm3(Predicted)
storage temp.  2-8°C
solubility  DMSO: 19 mg/mL
form  solid
pka 14.59±0.23(Predicted)
color  white
biological source synthetic (organic)
Merck  14,6869
Stability: Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 1 week.
InChIKey AHLBNYSZXLDEJQ-FWEHEUNISA-N
SMILES C(O[C@H](C[C@H]1[C@H](CCCCCC)C(=O)O1)CCCCCCCCCCC)(=O)[C@H](CC(C)C)NC=O
CAS DataBase Reference 96829-58-2(CAS DataBase Reference)

Description and Uses

Orlistat was launched in the UK as Xenical for the long-term treatment of obesity, preferably in conjunction with a moderately reduced calorie diet. Orlistat is a tetrahydro-derivative of the natural hypolipaemic lipstatin (from Streptomyces toxyfncini) and can be obtained either by hydrogenation of lipstatine or by several different synthetic ways involving many steps from ( S ) - rnalic acid. Orlistat is a potent inhibitor of gastrointestinal lipases required for the lipolysis and digestion of dietary fat, in particular of pancreatic lipase ; as a result, it prevents the absorption of about one third of the fat contained in food and acts as an effective weight-reducing therapy. The outcomes of several clinical trials involving thousands of obese patients showed that Orlistat promotes a significant weight loss (often between 5 and 10% after one year) and improves cardiovascular risk factors such as total cholesterol, LDL/HDL ratio, blood glucose levels, insulin, blood pressure. Orlistat has minimal systemic absorption, the majority of the compound itself being recovered in the feces ; it does not affect other gastrointestinal processes, or the absorption of other rnacronutrients such as carbohydrates and proteins.

Orlistat is an antiobesity agent. Orlistat is an pancreatic lipase inhibitor.

Safety

Symbol(GHS)  Exclamation Mark (GHS07)
GHS07
Signal word  Warning
Hazard statements  H302-H412
Precautionary statements  P273
PPE Eyeshields, Gloves, type N95 (US)
WGK Germany  3
RTECS  OH3167600
HS Code  29322090
Storage Class 11 - Combustible Solids
Hazardous Substances Data 96829-58-2(Hazardous Substances Data)

RELATED PRODUCTS